These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 32489127)
41. NTRK-rearranged Cervical Sarcoma: Expanding the Clinicopathologic Spectrum. Hodgson A; Pun C; Djordjevic B; Turashvili G Int J Gynecol Pathol; 2021 Jan; 40(1):73-77. PubMed ID: 32044823 [TBL] [Abstract][Full Text] [Related]
42. Larotrectinib followed by selitrectinib in a novel Goh XN; Seng MS; Loh AHP; Gupta A; Chang KTE; Iyer P J Oncol Pharm Pract; 2021 Mar; 27(2):485-489. PubMed ID: 32693686 [TBL] [Abstract][Full Text] [Related]
43. Unclassified mesenchymal sarcoma with NTRK1-KHDRBS1 gene fusion: a case report of long-term tumor-free survival with crizotinib treatment. Chen W; Wang H; Jiang D; Luan L; Zhou Y; Hou Y World J Surg Oncol; 2021 Apr; 19(1):136. PubMed ID: 33941195 [TBL] [Abstract][Full Text] [Related]
44. [Clinicopathological and molecular characteristics of NTRK-rearranged spindle cell neoplasms in the gastrointestinal tract]. Jian XY; Gao HQ; Zhao ZH; Wang F; Zhang L; Ma YH Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):598-604. PubMed ID: 38825906 [No Abstract] [Full Text] [Related]
45. Recurrent Khuong-Quang DA; Brown LM; Wong M; Mayoh C; Sexton-Oates A; Kumar A; Pinese M; Nagabushan S; Lau L; Ludlow LE; Gifford AJ; Rodriguez M; Desai J; Fox SB; Haber M; Ziegler DS; Hansford JR; Marshall GM; Cowley MJ; Ekert PG Cold Spring Harb Mol Case Stud; 2020 Dec; 6(6):. PubMed ID: 33144287 [TBL] [Abstract][Full Text] [Related]
46. BRAF-rearranged spindle cell mesenchymal neoplasm with a predominant lipofibromatosis-like neural tumor pattern and co-expression of CD34, S100 protein, and markers associated with perineurial differentiation: A rare case with potential diagnostic pitfall. Sun K; Ru GQ; Zhao M J Cutan Pathol; 2022 Mar; 49(3):278-283. PubMed ID: 34632612 [TBL] [Abstract][Full Text] [Related]
47. Uterine Sarcoma With EML4::NTRK3 Fusion: A Spectrum of Mesenchymal Neoplasms Harboring Actionable Gene Fusions. de Castro JVA; Dos Santos PJS; Mantoan H; Baiocchi G; Bovolim G; Torrezan G; Corassa M; do Nascimento AG; De Brot M; Costa FD; De Brot L Int J Gynecol Pathol; 2024 Jan; 43(1):56-60. PubMed ID: 37668341 [TBL] [Abstract][Full Text] [Related]
48. Intestinal infantile fibrosarcoma with translocation of NTRK. A case report and review of the literature. Soler PM; Duque MSR; Juan GM; Terán AKC; Calvo ART; Cobo MLC Rev Esp Patol; 2023; 56(2):76-81. PubMed ID: 37061245 [TBL] [Abstract][Full Text] [Related]
49. Activity of Entrectinib in a Patient With the First Reported Sigal D; Tartar M; Xavier M; Bao F; Foley P; Luo D; Christiansen J; Hornby Z; Maneval EC; Multani P J Natl Compr Canc Netw; 2017 Nov; 15(11):1317-1322. PubMed ID: 29118225 [TBL] [Abstract][Full Text] [Related]
51. FGFR1 gene fusions in a subset of pediatric mesenchymal tumors: Expanding the genetic spectrum of tumors sharing histologic overlap with infantile fibrosarcoma and "NTRK-rearranged" spindle cell neoplasms. Warmke LM; Al-Ibraheemi A; Wang L; Parham D; Rudzinski ER; Stohr BA; Miles C; Habeeb O; Davis JL Genes Chromosomes Cancer; 2023 Nov; 62(11):641-647. PubMed ID: 37265193 [TBL] [Abstract][Full Text] [Related]
52. The oncogenic roles of NTRK fusions and methods of molecular diagnosis. Aref-Eshghi E; Lin F; Li MM; Zhong Y Cancer Genet; 2021 Nov; 258-259():110-119. PubMed ID: 34710798 [TBL] [Abstract][Full Text] [Related]
53. [Clinicopathological features of gastric carcinomas with NTRK-rearrangement/amplification: report of four cases]. Xu AD; Fu Y; Pu XH; Wu HY; Sun Q; Fan XS Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):454-459. PubMed ID: 37106286 [No Abstract] [Full Text] [Related]
54. New fusion sarcomas: histopathology and clinical significance of selected entities. Miettinen M; Felisiak-Golabek A; Luiña Contreras A; Glod J; Kaplan RN; Killian JK; Lasota J Hum Pathol; 2019 Apr; 86():57-65. PubMed ID: 30633925 [TBL] [Abstract][Full Text] [Related]
55. [Clinicopathological characteristics of NTRK-rearranged mesenchymal tumors in childhood]. Yin MZ; Ma J; He Q; Shen P; Chen JF; Jin XT; Zhang ZD; Kuick CH; Chen HY; Ng EHQ; Aw SJ; Chang KTE Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):675-680. PubMed ID: 32610377 [No Abstract] [Full Text] [Related]
56. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms. Amin SM; Haugh AM; Lee CY; Zhang B; Bubley JA; Merkel EA; Verzì AE; Gerami P Am J Surg Pathol; 2017 Apr; 41(4):491-498. PubMed ID: 27776007 [TBL] [Abstract][Full Text] [Related]
57. NTRK-Fusion Sarcoma of the Uterine Cervix: Report of 2 Cases With Comparative Clinicopathologic Features. Nilforoushan N; Wethington SL; Nonogaki H; Gross J; Vang R; Xing D Int J Gynecol Pathol; 2022 Nov; 41(6):642-648. PubMed ID: 34723848 [TBL] [Abstract][Full Text] [Related]
58. Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors. Davis JL; Lockwood CM; Stohr B; Boecking C; Al-Ibraheemi A; DuBois SG; Vargas SO; Black JO; Cox MC; Luquette M; Turpin B; Szabo S; Laetsch TW; Albert CM; Parham DM; Hawkins DS; Rudzinski ER Am J Surg Pathol; 2019 Apr; 43(4):435-445. PubMed ID: 30585824 [TBL] [Abstract][Full Text] [Related]
59. NUTM2A-CIC fusion small round cell sarcoma: a genetically distinct variant of CIC-rearranged sarcoma. Sugita S; Arai Y; Aoyama T; Asanuma H; Mukai W; Hama N; Emori M; Shibata T; Hasegawa T Hum Pathol; 2017 Jul; 65():225-230. PubMed ID: 28188754 [TBL] [Abstract][Full Text] [Related]